Imperagen, developing a breakthrough technology needed to bring ultra-fast enzyme engineering to market

Imperagen,开发将超快速酶工程推向市场所需的突破性技术

基本信息

  • 批准号:
    10065705
  • 负责人:
  • 金额:
    $ 37.14万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Collaborative R&D
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

There is a global urgency to address the climate emergency and the environmental disaster from unsustainable industrial activity. Chemical manufacturing depends on highly polluting petrochemical-based processes that use substantial energy, produce toxic waste and dependant on increasingly scarce metallic catalysts. Chemical modification of compounds that introduces new chemical properties is required across the chemical industry and is critical to produce products that we depend upon due to their valuable properties, but with a substantial environmental cost.There is however, a natural solution. Enzymes are biological molecular scale factories that can perform these chemical modifications but with the advantage of working at low temperatures, mild conditions and biodegradability. Enzymes are one of the key solutions to maintain industrial processes in the face of climate change. Enzyme-based synthesis technology can introduce specific chemical modifications into essential chemicals such as pharmaceuticals, materials and consumer products, but in a sustainable manner. The problem, however, is that development of enzymes for a new chemical process is highly complex. Due to the complex molecular structure of an enzyme, finding improvements is like searching for needle in a haystack. It is costly and takes months of development, requires significant labour with highly unpredictable outcomes of success.To meet the market need, Imperagen (A UK based Spin Out from The University of Manchester) is developing an ultra-fast enzyme engineering platform, which can rapidly re-engineer enzymes for existing chemical engineering processes. This project will be used to develop and adopt a new and significant addition to Imperagen's technology. This breakthrough will dramatically increase its speed, efficiency and throughput of the technology and build an enzyme engineering platform that can deliver down to weeks, not months, allowing us to bring new products to market at a much accelerated and efficient rate.Our proprietary technology presents a huge commercial opportunity if successfully deployed, but at present is limited by key process bottlenecks. Removal of these bottlenecks through this project will be highly challenging and require innovative solutions to be developed. However, successful deployment will enable the realisation of our ultra-fast enzyme engineering platform, opening up new commercial opportunities into multiple high value market sections.
全球迫切需要应对气候紧急情况和不可持续的工业活动造成的环境灾难。化学品制造依赖于高污染的石油化工工艺,这些工艺消耗大量能源,产生有毒废物,并依赖于日益稀缺的金属催化剂。对化合物进行化学改性以引入新的化学性质是整个化学工业所需要的,对于生产我们所依赖的产品至关重要,因为它们具有宝贵的特性,但需要付出巨大的环境成本。然而,有一种天然的解决方案。酶是生物分子规模的工厂,可以进行这些化学修饰,但具有在低温,温和条件和生物降解性下工作的优点。酶是应对气候变化维持工业流程的关键解决方案之一。基于酶的合成技术可以将特定的化学修饰引入基本化学品,如药物,材料和消费品,但以可持续的方式。然而,问题是,开发用于新化学过程的酶是非常复杂的。由于酶的复杂分子结构,寻找改进就像大海捞针。为了满足市场需求,Imperagen(一家英国曼彻斯特大学的Spin Out)正在开发一个超快速酶工程平台,它可以快速地重新设计现有化学工程过程中的酶。该项目将用于开发和采用Imperagen技术的新的重要补充。这一突破将大大提高其速度,效率和技术的吞吐量,并建立一个酶工程平台,可以交付到几周,而不是几个月,使我们能够把新产品推向市场,在更快和更有效的速度。我们的专有技术,如果成功部署,提供了一个巨大的商业机会,但目前受到关键工艺瓶颈的限制。通过这一项目消除这些瓶颈将具有很大的挑战性,需要制定创新的解决方案。然而,成功部署将使我们的超快速酶工程平台得以实现,为多个高价值市场领域开辟新的商业机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship

相似海外基金

Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Developing behavioural methods to assess pain in horses
开发评估马疼痛的行为方法
  • 批准号:
    2686844
  • 财政年份:
    2025
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Developing eye models to improve eye treatments and contact/intraocular lens technologies
开发眼部模型以改善眼部治疗和隐形眼镜/人工晶状体技术
  • 批准号:
    2608661
  • 财政年份:
    2025
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Flok Health: Developing a pocket physiotherapist to deliver personalised healthcare at population scale
Flok Health:开发袖珍物理治疗师以在人口规模上提供个性化医疗保健
  • 批准号:
    10100082
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Collaborative R&D
Developing systemic interventions for intimate partner financial abuse
制定针对亲密伴侣经济虐待的系统干预措施
  • 批准号:
    DP240101075
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Discovery Projects
NESP MaC Project 4.5– Developing an Integrated Pest Management Framework for Feral Pigs in Coastal Environments 2024-2026 (NAILSMA)
NESP MaC 项目 4.5 — 为 2024-2026 年沿海环境中的野猪制定综合害虫管理框架 (NAILSMA)
  • 批准号:
    global : ba1e00f0-9953-4c17-b990-ba7aed84ce07
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
Developing and Visualising a Retrieval-Augmented Deep Learning Model for Population Health Management
开发和可视化用于人口健康管理的检索增强深度学习模型
  • 批准号:
    2905946
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Developing functionalised electrospun scaffolds to exploit neural stromal interactions in wound healing
开发功能化电纺支架以利用神经基质相互作用促进伤口愈合
  • 批准号:
    2910663
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Studentship
Developing a Census Based Generative Geodemographic Classification System
开发基于人口普查的生成地理人口分类系统
  • 批准号:
    ES/Z50273X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Research Grant
Developing new tests and treatments to enable prevention of osteoarthritis.
开发新的测试和治疗方法以预防骨关节炎。
  • 批准号:
    MR/Y003470/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.14万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了